Therefore, agents that can inhibit the transfer of melanosomes and/or accelerate epidermal turnover can result in the whitening of the skin
Since osteoporosis and obesity are two diseases that affect a vast majority of postmenopausal women concomitantly, using a single drug that is Food and Drug Administration (FDA) approved for obesity to prevent and manage both osteoporosis and obesity could improve the quality of life and decrease the complications and medical costs that occur as a result of both diseases
Semaglutide is a prescription medication classified as a GLP-1 receptor agonist (glucagon-like peptide-1 receptor agonist)
HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers
Peluso et al., 2022), although nicotinamide mononucleotide (NMN) supplementation extended the median lifespan of female, but not male, mice by 8.5% (Kane et al., 2024)